Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.gov public full text Public Domain

Study of Sunitinib in Patients With Von Hippel-Lindau (VHL) Disease

Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie · 2010
ClinicalTrials.gov · Datasets · License: Public Domain · 2010
Open Source ↗
VHL patients may benefit from sunitinib. This study will investigate the following objectives : PRIMARY OBJECTIVE * To determine the objective response rate according to RECIST criteria, in VHL patients with advanced tumors or tumors untreatable by other means, and treated with sunitinib. SECONDARY OBJECTIVES * To evaluate the safety and tolerability of sunitinib in VHL patients according to the NCI-CTC criteria Version 3.0. * To determine the following time-to-event endpoints: overall survival, time to disease progression, progression free survival, time to response and duration of response. * To evaluate quality of life in VHL patients receiving sunitinib.
Conceptio Open Archive

Analyze & explore related research in Conceptio

Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.

This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 1151614
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive